MORGAN STANLEY - VIRPAX PHARMACEUTICALS INC ownership

VIRPAX PHARMACEUTICALS INC's ticker is VRPX and the CUSIP is 928251107. A total of 14 filers reported holding VIRPAX PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of VIRPAX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$120
-25.9%
1500.0%0.00%
Q2 2023$162
+37.3%
1500.0%0.00%
Q1 2023$118
-82.4%
150
-86.1%
0.00%
Q4 2022$669
-33.1%
1,076
+0.9%
0.00%
Q3 2022$1,000
-96.7%
1,066
-94.1%
0.00%
Q2 2022$30,000
-82.8%
18,016
-77.1%
0.00%
Q1 2022$174,000
+987.5%
78,511
+1504.9%
0.00%
Q4 2021$16,000
+45.5%
4,892
+119.9%
0.00%
Q3 2021$11,000
+266.7%
2,225
+210.8%
0.00%
Q2 2021$3,0007160.00%
Other shareholders
VIRPAX PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 988,165$614,9350.54%
Quantum Private Wealth, LLC 10,000$6,2230.00%
Warberg Asset Management LLC 17,012$10,5610.00%
Belpointe Asset Management LLC 19,045$11,8520.00%
OSAIC HOLDINGS, INC. 600$00.00%
PNC FINANCIAL SERVICES GROUP, INC. 100,875$62,7440.00%
WELLS FARGO & COMPANY/MN 59$370.00%
NORTHERN TRUST CORP 15,221$9,4720.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 66,038$410.00%
View complete list of VIRPAX PHARMACEUTICALS INC shareholders